References
- Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic; a double blind comparison with chlorpromazine. Archives in General Psychiatry 1988; 45: 789–796
- Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of Clozapine. Epidemiology 1997; 8: 671–677
- Meltzer HY. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. Journal of Clinical Psychiatry 1999; 60(Suppl 12)47–50
- Honigfeld G. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Psychiatric Services 1996; 47: 52–56
- Reinders J, Parsonage W, Lange D, Potter JM, Plever S. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Australian and New Zealand Journal of Psychiatry 2004; 38: 915–922
- Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. British Mecical Journal 2001; 322: 1207–1209
- Hagg S, Spigset O, Bate A, Soderstrom TG. Myocarditis related to clozapine treatment. Journal of Clinical Psychopharmacology 2001; 21: 382–388
- Grenade LL, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. New England Journal of Medicine 2001; 345: 224
- Kilian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841–1845
- Tirupati S. Clozapine and heart in the Hunter region. Australian and New Zealand Journal of Psychiatry 2006; 40: 97
- Kay SE, Doery J, Sholl D. Clozapine associated pericarditis and elevated troponin I. Australian and New Zealand Journal of Psychiatry 2002; 36: 143–144
- Murko A, Clarke S, Black DW. Clozapine and pericarditis with pericardial effusion. American Journal of Psychiatry 2002; 159: 494
- Bandelow B, Degner D, Kreusch U, Ruther E. Myocarditis under therapy with clozapine. Schizophrenia Research 1995; 17: 293–294
- Wooltorton E. Antipsychotic clozapine (Clozaril); myocarditis and cardiovascular toxicity. Canadian Medical Association Journal 2002; 166: 1185–1186
- Burke AP, Saenger J, Mullick F, Virmani R. Hypersensitivity myocarditis. Archives of Pathological and Laboratory Medicine 1991; 115: 764–769
- Varma S, Achan K. Dysrhythmia associated with clozapine. Australian and New Zealand Journal of Psychiatry 1999; 33: 118–119
- Koren W, Kreis Y, Duchowiczny K, et al. Lactic acidosis and fatal myocardial failure due to clozapine. Annals of Pharmacotherapy 1997; 31: 168–170
- Lapierre YD, Ghadirian A, St. Laurent J, Chaudhry RP. Clozapine in acute schizophrenia – efficacy and toxicity. Current Therapeutic Research 1980; 27: 391–400
- Phan KLD, Taylor SF. Clozapine-associated cardiomyopathy. Psychosomatics 2002; 43: 248
- Reid P, McArthur M, Pridmore S. Clozapine rechallenge after myocarditis. Australian and New Zealand Journal of Psychiatry 2001; 35: 249